Hepatitis C core antigen: a simple predictive marker for treatment response to the new direct-acting antiviral drugs in chronic HCV Egyptian patients

Egyptian Liver Journal

Table 3 Correlation between baseline levels of HCVcAg (Peiu/ml) and HCV RNA (IU/ml) assays among the studied groups

Baseline HCV RNA (IU/ml)	Baseline HCVcAg (Peiu/ml)
Baseline HCV RNA (IU/ml)	r	P value
Group I: mild viremia group (No. = 140)	0.752	0.002*
Group II: moderate viremia group (No. = 80)	0.976	< 0.001**
Group III: severe viremia group (No. = 60)	1.00	< 0.001**